Human CD20/MS4A1 recombinant protein from ProteoGenix; catalogue PX-P6274; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The human CD20/MS4A1 recombinant protein is a type I membrane protein composed of a single extracellular loop, a single transmembrane domain, and a cytoplasmic tail. It is expressed on the surface of B-cells and is involved in B-cell activation and proliferation.
Activity of Human CD20/MS4A1 Recombinant ProteinThe activity of the human CD20/MS4A1 recombinant protein is mediated by its interaction with other proteins, such as CD19 and CD21, which are involved in B-cell activation and proliferation. The CD20/MS4A1 protein is also involved in the regulation of B-cell differentiation and maturation.
Application of Human CD20/MS4A1 Recombinant ProteinThe human CD20/MS4A1 recombinant protein is a promising target for the development of antibody-drug conjugates for the treatment of B-cell malignancies. Antibodies targeting the CD20/MS4A1 protein have been successfully used in clinical trials, demonstrating their potential as an effective treatment for various B-cell malignancies.
ProteoGenix catalogue number PX-P6274. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Purity: >85% by SDS-PAGE; Molecular weight: 19.58 kDa; Tag: N-Terminal His & N-Terminal Trx Tags; Fragment: Ile143-Ser188; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.; Applications: ELISA, WB.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
